10404 related articles for article (PubMed ID: 10721489)
1. Cell adhesion molecules in the development and progression of malignant melanoma.
Johnson JP
Cancer Metastasis Rev; 1999; 18(3):345-57. PubMed ID: 10721489
[TBL] [Abstract][Full Text] [Related]
2. Cellular adhesion pathways and metastatic potential of human melanoma.
McGary EC; Lev DC; Bar-Eli M
Cancer Biol Ther; 2002; 1(5):459-65. PubMed ID: 12496470
[TBL] [Abstract][Full Text] [Related]
3. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
4. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
5. Gene regulation in melanoma progression by the AP-2 transcription factor.
Bar-Eli M
Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
[TBL] [Abstract][Full Text] [Related]
6. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
7. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.
Hsu MY; Meier FE; Nesbit M; Hsu JY; Van Belle P; Elder DE; Herlyn M
Am J Pathol; 2000 May; 156(5):1515-25. PubMed ID: 10793063
[TBL] [Abstract][Full Text] [Related]
9. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
10. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
Johnson JP; Bar-Eli M; Jansen B; Markhof E
Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
[TBL] [Abstract][Full Text] [Related]
11. The distribution of cellular adhesion molecules in pigmented skin lesions.
van Duinen CM; van den Broek LJ; Vermeer BJ; Fleuren GJ; Bruijn JA
Cancer; 1994 Apr; 73(8):2131-9. PubMed ID: 7512443
[TBL] [Abstract][Full Text] [Related]
12. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.
Lehmann JM; Riethmüller G; Johnson JP
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381
[TBL] [Abstract][Full Text] [Related]
13. Role of AP-2 in tumor growth and metastasis of human melanoma.
Bar-Eli M
Cancer Metastasis Rev; 1999; 18(3):377-85. PubMed ID: 10721491
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
16. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
Shih IM; Elder DE; Hsu MY; Herlyn M
Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174
[TBL] [Abstract][Full Text] [Related]
18. Integrins and other adhesion molecules involved in melanocytic tumor progression.
Edward M
Curr Opin Oncol; 1995 Mar; 7(2):185-91. PubMed ID: 7756384
[TBL] [Abstract][Full Text] [Related]
19. Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
Johnson JP; Lehmann JM; Stade BG; Rothbächer U; Sers C; Riethmüller G
Invasion Metastasis; 1989; 9(6):338-50. PubMed ID: 2574717
[TBL] [Abstract][Full Text] [Related]
20. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
